Trial Profile
Clinical Trials Insight: 700042650
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Mar 2009
Price :
$35
*
At a glance
- Drugs Brivudine (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors SciClone Pharmaceuticals
- 19 Mar 2009 New trial record.